Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
Blokirali ste korisnika/cu @FASinicropeMD
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @FASinicropeMD
-
Frank Sinicrope, MD proslijedio/la je Tweet
Wuhan's first hospital built specially for receiving coronavirus patients completed on Sunday after 10 days of speedy construction. It will be managed by China's military medical system and start operation on Monday.pic.twitter.com/bXYkfaFvEA
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Frank Sinicrope, MD proslijedio/la je Tweet
Is nearly half of Early-Onset CRC(colorectal cancer) preventable?pic.twitter.com/WS11b6kUjT
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Frank Sinicrope, MD proslijedio/la je Tweet
Wow!! Impressive response rate to Gem Cis in BRCA+ pancreatic cancer (ORR > 60%). New benchmark for this subset. Thanks to patient volunteers and research teams at
@sloan_kettering@pmcancercentre@university@UMRogelCancer@tcddublin and otherspic.twitter.com/74S54Vhewp
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Frank Sinicrope, MD proslijedio/la je Tweet
A consensus statement on cancer associated fibroblasts (with the Who’s Who of CAF biology!) emanating from a
@CSHL@cshlbanbury meeting in 2019.#openaccess so enjoy!@AshaniTW@ednacukierman@megeblad@claus_jorgensen@MaraShermanLab@NatureRevCancerhttps://www.nature.com/articles/s41568-019-0238-1 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Frank Sinicrope, MD proslijedio/la je Tweet
Important message by
@EileenMOReilly and an approach I many others have adapted in BRCA+#PancreaticCancer -1st line platinum based regimen followed by parp maintenance is a top approach in this subset-parp haters don’t @ mehttps://twitter.com/ASCO_pubs/status/1220737492485201921 …
1:03Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Frank Sinicrope, MD proslijedio/la je Tweet
Strong OS results from IMbrave150. A big step forward for cancer immunotherapy with atezo+bev and it’s impact on global health. Great for HCC patients. Wish we had this for my grandfather when he needed it years ago.
#cancer#immunotherapy#HCC#liver#pdl1 https://twitter.com/DanChenMDPhD/status/1186310970672480256 …pic.twitter.com/8AcayMWSBJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Equivalent efficacy of doublet and triplet reported in NEJM paper now confirmed.https://twitter.com/TGeorgeMD/status/1221147926379913217 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Impressive data; should be new std of care for first line tx of MSI-H metastatic CRC.https://twitter.com/CathyEngMD/status/1221090746503028738 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Frank Sinicrope, MD proslijedio/la je Tweet
Dr. Susan Bullman of
@fredhutch recaps her#GI20 keynote lecture: How the#Microbiome Impacts Cancer, Immunity, and Response to Therapy https://fal.cn/36d6x pic.twitter.com/GFIRAnIADjHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Frank Sinicrope, MD proslijedio/la je Tweet
This patient page on chemotherapy-induced peripheral
#neuropathy (#CIPN) reviews risks, prevention, symptoms, and management of this common and challenging complication of#cancer treatment. https://ja.ma/2Gi66HF#ThrowbackThursdayHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Frank Sinicrope, MD proslijedio/la je Tweet
Very nice summary of the standard of care in GEJ cancers in 2020 by Dr. Harry Yoon! And outstanding presentations in GE cancers session in the
#GI20!#cancer#CancerResearch#clinicaltrialspic.twitter.com/SSoQIEi6dc
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Frank Sinicrope, MD proslijedio/la je Tweet
#NewsInDepth Q&A: Christina Curtis on Computational and Systems Biology@cncurtis@StanfordMed The article is freely available here: http://bit.ly/2NRme75 pic.twitter.com/f2lU0efns8
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Frank Sinicrope, MD proslijedio/la je Tweet
Thanks
@KellyKhunt for inviting me to speak@MDAndersonNews conference and highlight our efforts to characterize immune changes in the TME after standard therapy to include after atezolizumab+abraxane as part of TRIBUTE@BCRFcure@CancerResearch@parkerici@DanaFarberhttps://twitter.com/KellyKhunt/status/1218699649822941184 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Frank Sinicrope, MD proslijedio/la je Tweet
Great progress against cancer - here with a eloquent commentary.https://twitter.com/TheCancerLetter/status/1216412110420348928 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Frank Sinicrope, MD proslijedio/la je Tweet
Very happy to have this manuscript completed, and the excellent partnership with
@ImmunityCP. This one was almost three years in the making- and required evolution of the entire#cancer#immunotherapy field to make possible. The importance of#Collaboration.@sitcancer@AACRhttps://twitter.com/ImmunityCP/status/1217114443584282631 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Frank Sinicrope, MD proslijedio/la je Tweet
#ASCO2019,#ColonCancer,#Immunoscore Phase III randomized clinical trial in stage III colon cancer patients (n=1062) shows significant predictive value of Immunoscore.@APHP#HEGP#GERCOR#FFCD@GroupeUNICANCER#FranckPages@JeromeGalon@Inserm@HalioDxpic.twitter.com/sIIWtRXmWD
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Frank Sinicrope, MD proslijedio/la je Tweet
Come join us for our Education and Support Series on Thursday, January 16, 2020! Information and strategies to manage cancer-related fatigue will be shared. We hope to see you there!
#YoungOnset#Workshoppic.twitter.com/UgrLoH5oPY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Frank Sinicrope, MD proslijedio/la je Tweet
My patient (in the back somewhere) on Keynote-001 with
#Lambrolizumab now#Pembrolizumab able to see the birth of 7 grandchildren due to the#PD1 breakthrough (BTW he has 10 grandchildren) we are both#blessed#clinicaltrials@angelesclinic@MelanomaReAlli@AIMatMelanomapic.twitter.com/2oynFcIeHz
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Frank Sinicrope, MD proslijedio/la je Tweet
The prospective clinical MSKCC NGS cohort is now >50,000 samples sequenced. Thanks to the hundreds of physicians, laboratory technicians, data scientists, nurses and support staff
@sloan_kettering who have made this initiative possible. A few thoughts on what we have learned.pic.twitter.com/9ra4tuqUg7
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Frank Sinicrope, MD proslijedio/la je Tweet
Know an
#oncologist focusing on#breastcancer disparities? Encourage them to apply by Jan 21, 2020! https://bit.ly/2M2At8l#bcsm#healthdisparities#cancerdisparities#ConquerCancerPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.